Gastric surgical adjuvant radiotherapy consensus report: Rationale and treatment implementation

  • Smalley S
  • Gunderson L
  • Tepper J
 et al. 
  • 79


    Mendeley users who have this article in their library.
  • 137


    Citations of this article.


Purpose: Radiation therapy has recently emerged as a pivotal modality in the management of completely resected, high-risk gastric cancer. The recently published results of the Intergroup 0116 Gastric Surgical Adjuvant Trial randomized high-risk (T3,4 and/or node positive), completely resected gastric or gastroesophageal adenocarcinomas to receive either observation alone or radiochemotherapy after complete resection. Radiochemotherapy produced significant improvements in relapse-free (p < 0.0001) and overall survival (p = 0.01). Radiation oncologists must now clearly comprehend the principles governing the rationale supporting this therapy to apply it to those afflicted with this disease. This paper represents a consensus report reviewing data supporting radiotherapy, important clinical and anatomic issues related to radiotherapy, and details of the practical application of radiation therapy to commonly occurring clinical presentations. Supportive therapy during and after radiochemotherapy is also discussed. Copyright © 2002 Elsevier Science Inc.

Author-supplied keywords

  • Gastric surgical adjuvant radiotherapy
  • Patterns of failure
  • Phase III trials
  • Radiation treatment planning
  • Supportive care

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free